← Eichor
Study identifier: NCT07617896 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Intravesical Aminophylline to Facilitate Ureteroscopic Access in Children With Distal Ureteral Stones.

Condition: Pediatric Urolithiasis · Distal Ureteral Stone · Ureteral Calculi  ·  Sponsor: Beni-Suef University

PhasePhase 2
Planned participants60
Who can joinAll sexes, 2 Years to 18 Years
Healthy volunteersNo

About this study

This study will evaluate whether intravesical aminophylline can facilitate semi-rigid ureteroscopic access in children with distal ureteral stones when the first gentle attempt to enter the ureter is unsuccessful. Children scheduled for semi-rigid ureteroscopy for distal ureteral stones will first undergo the standard gentle attempt to pass the ureteroscope through the ureteric orifice and intramural ureter. If access is achieved, the child will continue standard treatment and will not be randomized. If access is not achieved, the child will be randomized during the operation to receive either intravesical aminophylline or intravesical normal saline placebo. The study solution will be instilled into the bladder for approximately 5 minutes, then drained, and a second gentle ureteroscopic access attempt will be made. The main outcome is successful same-session passage of the intended semi-rigid ureteroscope without balloon dilation. The study will also assess the need for JJ stenting and deferred ureteroscopy, same-session stone treatment, operative outcomes, complications, and early aminophylline-related safety.

This description comes directly from the study's public registry record.

Talk to the study team

Hany F Badawy, Md  ·  +201149525028  ·  HANYFATHY86@GMAIL.COM

Ahmed Gmal, MD  ·  +20 11 18206022  ·  Drhanyfathy86@GMAIL.COM

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Urology- Beni-Suef University HospitalsBanī Suwayf, Beni Suweif Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07617896